(2001) investigated AOD9604 in obese Zucker rats and observed that chronic administration was associated with reduced body weight gain without changes in IGF-1 levels or glucose tolerance, distinguishing its activity profile from that of full-length growth hormone [1]
They are banned because they can enhance muscle growth, recovery and performance
If, however, you're designing a study specifically to test the local gut effects of peptides, then an oral formulation might be your test article, but you'd be doing so with the full understanding of its limitations
The appetite suppression pathway (GLP-1): Retatrutide crosses the blood-brain barrier and acts on hypothalamic neurons that regulate hunger and satiety
Both improve dramatically with tirzepatide
Evidence-based guideline update: NSAIDS and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
